These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 988964)

  • 81. Oral sotalol in pediatric atrial ectopic tachycardia.
    Colloridi V; Perri C; Ventriglia F; Critelli G
    Am Heart J; 1992 Jan; 123(1):254-6. PubMed ID: 1729843
    [No Abstract]   [Full Text] [Related]  

  • 82. Effect of Sotalol on clinical arrhythmias.
    Prakash R; Parmley WW; Allen HN; Matloff JM
    Am J Cardiol; 1972 Mar; 29(3):397-400. PubMed ID: 4110596
    [No Abstract]   [Full Text] [Related]  

  • 83. Comparability of the electrophysiologic responses and plasma and myocardial tissue concentrations of sotalol and its d stereoisomer in the dog.
    Gomoll AW; Lekich RF; Bartek MJ; Comereski CR; Antonaccio MJ
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):204-11. PubMed ID: 1697375
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pharmacokinetics and pharmacodynamics of mepindolol sulphate.
    Bonelli J; Hitzenberger G; Krause W; Wendt H; Speck U
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):169-76. PubMed ID: 6103882
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Electrophysiological properties of acute intravenous sotalol in man].
    Clémenty J; Falquier JF; Danis C; Bémurat M; Dallocchio M; Bricaud H
    Arch Mal Coeur Vaiss; 1981 Sep; 74(9):1089-97. PubMed ID: 6794520
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prazosin, pharmacokinetics and concentration effect.
    Bateman DN; Hobbs DC; Twomey TM; Stevens EA; Rawlins MD
    Eur J Clin Pharmacol; 1979 Sep; 16(3):177-81. PubMed ID: 499317
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pharmacokinetics and bioavailability of pinacidil capsules in human volunteers.
    Laher MS; Hickey MP
    J Int Med Res; 1985; 13(3):159-62. PubMed ID: 4007251
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalol.
    Kaplan HR; Commarato MA
    J Pharmacol Exp Ther; 1973 May; 185(2):395-405. PubMed ID: 4145046
    [No Abstract]   [Full Text] [Related]  

  • 89. Propranolol and sotalol as antagonists of isoproterenol-enhanced physiologic tremor.
    Pickles H; Perucca E; Fish A; Richens A
    Clin Pharmacol Ther; 1981 Sep; 30(3):303-10. PubMed ID: 6115732
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Sotalol in patients with Wolff-Parkinson-White syndrome.
    Kunze KP; Schlüter M; Kuck KH
    Circulation; 1987 May; 75(5):1050-7. PubMed ID: 3568305
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Prediction of sotalol-induced maximum steady-state QTc prolongation from single-dose administration in healthy volunteers.
    Le Coz F; Funck-Brentano C; Poirier JM; Kibleur Y; Mazoit FX; Jaillon P
    Clin Pharmacol Ther; 1992 Oct; 52(4):417-26. PubMed ID: 1424415
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Stereoselective disposition of (+/-)-sotalol at steady-state conditions.
    Fiset C; Philippon F; Gilbert M; Turgeon J
    Br J Clin Pharmacol; 1993 Jul; 36(1):75-7. PubMed ID: 8373714
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Pharmacokinetics and bioavailability of alizapride (author's transl)].
    Houin G; Bree F; Tillement JP
    Sem Hop; 1982 Feb; 58(6):339-44. PubMed ID: 6280299
    [No Abstract]   [Full Text] [Related]  

  • 94. Pharmacokinetics of terodiline in human volunteers.
    Karlén B; Andersson KE; Ekman G; Strömberg S; Ulmsten U
    Eur J Clin Pharmacol; 1982; 23(3):267-70. PubMed ID: 7173296
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Intravenous Sotalol: An Under Used Treatment Strategy.
    Kerin NZ
    Cardiology; 2018; 140(3):143-145. PubMed ID: 30016794
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pharmacokinetics of Flavoxate in man.
    Bertoli M; Conti F; Conti M; Cova A; Setnikar I
    Pharmacol Res Commun; 1976 Aug; 8(4):417-28. PubMed ID: 1026965
    [No Abstract]   [Full Text] [Related]  

  • 97. The kinetics of propylthiouracil in hyperthyroidism.
    Kampmann J; Skovsted L
    Acta Pharmacol Toxicol (Copenh); 1975 Sep; 37(3):201-10. PubMed ID: 1242605
    [No Abstract]   [Full Text] [Related]  

  • 98. Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.
    Bouchard J; Shepherd G; Hoffman RS; Gosselin S; Roberts DM; Li Y; Nolin TD; Lavergne V; Ghannoum M;
    Crit Care; 2021 Jun; 25(1):201. PubMed ID: 34112223
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations.
    Villiger A; Stillhart C; Parrott N; Kuentz M
    AAPS J; 2016 Jul; 18(4):933-47. PubMed ID: 27060007
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug.
    Khalil F; Läer S
    AAPS J; 2014 Mar; 16(2):226-39. PubMed ID: 24399240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.